Interestingly, a retrospective observational cohort study on 18 patients with PTC did identify two patients whose tumor volume increased following exposure to GLP-1RAs (43)
They're popular in both the wellness and medical weight loss worlds for good reason: theyre targeted, low-risk, and can deliver noticeable results over time
Goldstein T, Kark JD, Berry EM, Adler B, Ziv E, Raz I
Band 3, the human red cell chloride/bicarbonate anion exchanger (AE1, SLC4A1), in a structural context
Key highlights Tirzepatide (also known by FDA-approved brand names Mounjaro and Zepbound) is a dual receptor agonist (GLP-1/GIP) that helps reduce appetite, control blood sugar, and promote greater weight loss than single receptor GLP-1 receptor agonists, such as semaglutide
Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide delivery